{{Rsnum
|rsid=8072199
|Gene=NOS2
|Chromosome=17
|position=27789822
|Orientation=plus
|GMAF=0.259
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NOS2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 26.5 | 46.9 | 26.5
| HCB | 86.1 | 13.9 | 0.0
| JPT | 86.7 | 13.3 | 0.0
| YRI | 67.3 | 30.6 | 2.0
| ASW | 47.4 | 45.6 | 7.0
| CHB | 86.1 | 13.9 | 0.0
| CHD | 83.5 | 16.5 | 0.0
| GIH | 58.4 | 33.7 | 7.9
| LWK | 66.4 | 31.8 | 1.8
| MEX | 50.0 | 41.4 | 8.6
| MKK | 51.9 | 38.5 | 9.6
| TSI | 33.3 | 45.1 | 21.6
| HapMapRevision=28
}}
{{PMID Auto
|PMID=20374233
|Title=Analysis of Single Nucleotide Polymorphisms in the NOS2A Gene and Interaction with Smoking in Age-Related Macular Degeneration
|OA=1
}}

{{PMID|18663495|OA=1
}} Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease.

{{PMID|19505917|OA=1
}} Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors.

{{PMID|19723394|OA=1
}} Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}